<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04355975</url>
  </required_header>
  <id_info>
    <org_study_id>4303 - 2019-02042</org_study_id>
    <nct_id>NCT04355975</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes After Acute Pulmonary Embolism</brief_title>
  <acronym>ERASE PE</acronym>
  <official_title>Clinical Outcomes After Acute Pulmonary Embolism - The Bern Acute Pulmonary Embolism Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate safety and effectiveness of PE treatment according to the decision of the
      multi-disciplinary pulmonary embolism response team (PERT) and to define and optimize
      treatment indications, institutional algorithms and interventional techniques for PE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This single-center cohort study is designed to retrospectively and prospectively collect
      treatment and outcome data related to patients with PE and after activation of the PERT.
      Treatment information and outcomes after advanced treatment modalities, including systemic
      thrombolysis, catheter directed thrombolysis and surgical embolectomy, will be collected.

      Retrospective patient data will consist of treatment and health related outcomes of
      consecutive patients treated for acute and chronic PE between October 2017 and April 2020 (to
      assess the learning curve of the PERT) and of patients receiving surgical embolectomy between
      January 2001 and April 2020. The retrospective data will be derived from the local
      institutional dataset and will be transferred to the study database. Prospective patients
      will be included after May 2020.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>In-hospital death</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-procedural adverse events</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent VTE during follow-up</measure>
    <time_frame>up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory and functional deterioration after treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of chronic thromboembolic pulmonary hypertension (CTEPH)</measure>
    <time_frame>up to 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Medical Therapy / Anticoagulation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic Lysis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional Therapy for PE</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical Embolectomy</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        -  Patients with Acute PE

          -  Patients developing CTEPH
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients with pulmonary embolism matching the criteria for treatment
             according to the decision of the PERT.

          -  Written informed consent

        Exclusion Criteria:

          -  High probability of non-adherence to the follow up requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Stortecky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Bern University Hospital, University of Bern, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Stortecky, MD</last_name>
    <phone>+41 31 632 21 11</phone>
    <email>stefan.stortecky@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Bern - Inselspital</name>
      <address>
        <city>Bern</city>
        <state>BE</state>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Stortecky, MD</last_name>
      <phone>0041 31632 83 52</phone>
      <email>stefan.stortecky@insel.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Stortecky, MD</last_name>
      <phone>0041316322111</phone>
      <email>stefan.stortecky@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>May 1, 2020</last_update_submitted>
  <last_update_submitted_qc>May 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

